CY1111431T1 - Μεταλλαγμενες πρωτεϊνες πλακουντιου αυξητικου παραγοντα τυπου 1, μεθοδος παρασκευης και εφαρμογες αυτων - Google Patents
Μεταλλαγμενες πρωτεϊνες πλακουντιου αυξητικου παραγοντα τυπου 1, μεθοδος παρασκευης και εφαρμογες αυτωνInfo
- Publication number
- CY1111431T1 CY1111431T1 CY20111100200T CY111100200T CY1111431T1 CY 1111431 T1 CY1111431 T1 CY 1111431T1 CY 20111100200 T CY20111100200 T CY 20111100200T CY 111100200 T CY111100200 T CY 111100200T CY 1111431 T1 CY1111431 T1 CY 1111431T1
- Authority
- CY
- Cyprus
- Prior art keywords
- type
- preparation
- plumbing
- practical
- applications
- Prior art date
Links
- 238000000034 method Methods 0.000 title 2
- 239000003102 growth factor Substances 0.000 title 1
- 238000009428 plumbing Methods 0.000 title 1
- 101000595923 Homo sapiens Placenta growth factor Proteins 0.000 abstract 2
- 102100035194 Placenta growth factor Human genes 0.000 abstract 2
- 230000001613 neoplastic effect Effects 0.000 abstract 2
- 102000008300 Mutant Proteins Human genes 0.000 abstract 1
- 108010021466 Mutant Proteins Proteins 0.000 abstract 1
- 125000003275 alpha amino acid group Chemical group 0.000 abstract 1
- 239000002537 cosmetic Substances 0.000 abstract 1
- 125000000151 cysteine group Chemical group N[C@@H](CS)C(=O)* 0.000 abstract 1
- 230000037430 deletion Effects 0.000 abstract 1
- 238000012217 deletion Methods 0.000 abstract 1
- 238000003745 diagnosis Methods 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 230000001575 pathological effect Effects 0.000 abstract 1
- 235000018102 proteins Nutrition 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
- 238000006467 substitution reaction Methods 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
- C07K14/515—Angiogenesic factors; Angiogenin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/16—Emollients or protectives, e.g. against radiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Genetics & Genomics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Molecular Biology (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Toxicology (AREA)
- Dermatology (AREA)
- Gastroenterology & Hepatology (AREA)
- Vascular Medicine (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Wood Science & Technology (AREA)
- Epidemiology (AREA)
- Cardiology (AREA)
- Physics & Mathematics (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Plant Pathology (AREA)
- Mycology (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT2002RM000277A ITRM20020277A1 (it) | 2002-05-17 | 2002-05-17 | Muteine del fattore di crescita placentare tipo 1, metodo di preparazione e loro applicazioni. |
| EP03727958A EP1506295B1 (de) | 2002-05-17 | 2003-05-19 | Muteine des placental growth factor type 1, herstellungsmethode und anwendung davon |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CY1111431T1 true CY1111431T1 (el) | 2015-08-05 |
Family
ID=11456311
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CY20111100200T CY1111431T1 (el) | 2002-05-17 | 2011-02-16 | Μεταλλαγμενες πρωτεϊνες πλακουντιου αυξητικου παραγοντα τυπου 1, μεθοδος παρασκευης και εφαρμογες αυτων |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US7314734B2 (de) |
| EP (1) | EP1506295B1 (de) |
| JP (1) | JP4230450B2 (de) |
| KR (1) | KR101022934B1 (de) |
| CN (1) | CN1323167C (de) |
| AT (1) | ATE488590T1 (de) |
| AU (1) | AU2003234066B2 (de) |
| BR (1) | BR0309966A (de) |
| CA (1) | CA2485587C (de) |
| CY (1) | CY1111431T1 (de) |
| DE (1) | DE60334986D1 (de) |
| DK (1) | DK1506295T3 (de) |
| ES (1) | ES2356360T3 (de) |
| HK (1) | HK1079549A1 (de) |
| HR (1) | HRP20041178B1 (de) |
| IT (1) | ITRM20020277A1 (de) |
| MX (1) | MXPA04011405A (de) |
| PL (1) | PL209955B1 (de) |
| PT (1) | PT1506295E (de) |
| RU (1) | RU2344172C2 (de) |
| WO (1) | WO2003097688A2 (de) |
| ZA (1) | ZA200409943B (de) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1962096B1 (de) | 2002-11-16 | 2012-07-18 | Siemens Healthcare Diagnostics Products GmbH | SCD40L, PAPP-A und plazentaler-Wachstumsfaktor (PIGF) als biochemische Markerkombination bei kardiovaskulären Erkrankungen |
| DE102005022047A1 (de) | 2005-05-09 | 2006-11-30 | Dade Behring Marburg Gmbh | Bindungspartner des Plazentalen Wachstumsfaktors insbesondere gegen den Plazentalen Wachstumsfaktor gerichtete Antikörper, ihre Herstellung und Verwendung |
| JP2009100680A (ja) * | 2007-10-23 | 2009-05-14 | Univ Nagoya | ヒト全身性強皮症動物モデルの作製方法、ヒト全身性強皮症動物モデル及びその用途 |
| RU2523887C2 (ru) | 2008-01-07 | 2014-07-27 | Орто-Клиникал Дайэгностикс, Инк. | Калибратор/регулятор для синхронного анализа белков, способных к комплексообразованию друг с другом |
| EP2235529B1 (de) | 2008-01-07 | 2016-12-14 | Ortho-Clinical Diagnostics, Inc. | Bestimmung des sflt-1:angiogenesefaktorkomplexes |
| EP2295449A1 (de) | 2009-09-09 | 2011-03-16 | Dompe PHA.R.MA S.p.A. | PLGF-1 in homodimerer Form |
| CN103087153B (zh) | 2011-10-28 | 2015-05-06 | 上海市第一人民医院 | 一类新的抑制新生血管的小肽及其应用 |
| EP3003354B1 (de) | 2013-05-31 | 2019-02-06 | CoBioRes NV | Humanes plgf-2 für die prävention und behandlung von atherosklerotischem herzversagen |
| CN109134650A (zh) * | 2018-09-10 | 2019-01-04 | 宁波奥丞生物科技有限公司 | 抗人plgf单克隆抗体的制备方法 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1242149B (it) | 1990-09-27 | 1994-02-16 | Consiglio Nazionale Ricerche | Sequenza di nucleotidi codificante per una proteina umana con proprieta' regolative dell'angiogenesi |
| EP0506477B1 (de) * | 1991-03-28 | 1999-06-23 | Merck & Co. Inc. | Untereinheit-C des vaskulären endothelialen Zellwachstumsfaktors |
| SE9601245D0 (sv) * | 1996-03-29 | 1996-03-29 | Pharmacia Ab | Chimeric superantigens and their use |
| DE19748734A1 (de) * | 1997-11-05 | 1999-05-06 | Biotechnolog Forschung Gmbh | Verfahren zur Gewinnung von biologisch aktiven Dimeren von rekombinanten humanen Wachstumsfaktoren aus der Cystein-Knoten-Familie sowie Verwendung der gewonnenen Dimere |
| MXPA01012385A (es) * | 1999-06-03 | 2002-09-02 | Human Genome Sciences Inc | Proteinas angiogenicas y usos de las mismas. |
| ATE321069T1 (de) * | 2000-05-12 | 2006-04-15 | Vlaams Interuniv Inst Biotech | Verwendung von inhibitoren des plazenta wachstumsfactors für die behandlung einer pathologischen angiogenese, pathologischen arteriogenese, entzündung, tumorbildung und/oder gefässdurchlässigkeit (ödem) |
-
2002
- 2002-05-17 IT IT2002RM000277A patent/ITRM20020277A1/it unknown
-
2003
- 2003-05-19 ES ES03727958T patent/ES2356360T3/es not_active Expired - Lifetime
- 2003-05-19 PL PL372492A patent/PL209955B1/pl unknown
- 2003-05-19 DE DE60334986T patent/DE60334986D1/de not_active Expired - Lifetime
- 2003-05-19 AU AU2003234066A patent/AU2003234066B2/en not_active Ceased
- 2003-05-19 PT PT03727958T patent/PT1506295E/pt unknown
- 2003-05-19 CN CNB038112043A patent/CN1323167C/zh not_active Expired - Fee Related
- 2003-05-19 JP JP2004506360A patent/JP4230450B2/ja not_active Expired - Fee Related
- 2003-05-19 CA CA2485587A patent/CA2485587C/en not_active Expired - Fee Related
- 2003-05-19 BR BR0309966-0A patent/BR0309966A/pt not_active IP Right Cessation
- 2003-05-19 RU RU2004137000/13A patent/RU2344172C2/ru not_active IP Right Cessation
- 2003-05-19 AT AT03727958T patent/ATE488590T1/de active
- 2003-05-19 KR KR1020047018601A patent/KR101022934B1/ko not_active IP Right Cessation
- 2003-05-19 DK DK03727958.5T patent/DK1506295T3/da active
- 2003-05-19 EP EP03727958A patent/EP1506295B1/de not_active Expired - Lifetime
- 2003-05-19 MX MXPA04011405A patent/MXPA04011405A/es active IP Right Grant
- 2003-05-19 US US10/514,707 patent/US7314734B2/en not_active Expired - Fee Related
- 2003-05-19 WO PCT/IT2003/000296 patent/WO2003097688A2/en active Application Filing
-
2004
- 2004-12-08 ZA ZA2004/09943A patent/ZA200409943B/en unknown
- 2004-12-10 HR HRP20041178AA patent/HRP20041178B1/hr not_active IP Right Cessation
-
2005
- 2005-12-19 HK HK05111674A patent/HK1079549A1/xx not_active IP Right Cessation
-
2011
- 2011-02-16 CY CY20111100200T patent/CY1111431T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1111431T1 (el) | Μεταλλαγμενες πρωτεϊνες πλακουντιου αυξητικου παραγοντα τυπου 1, μεθοδος παρασκευης και εφαρμογες αυτων | |
| ES2199959T3 (es) | Procedimiento mejorado para el replegamiento de proteinas. | |
| BRPI0411112A (pt) | proteìna de fusão heteróloga, polinucleotìdeo, vetor, célula hospedeira, processo para produzir uma proteìna de fusão heteróloga, método para tratar um paciente, e, uso de proteìna de fusão heteróloga | |
| BRPI0511118A (pt) | polipeptìdeos de haemophilus influenzae não transcritos | |
| TR200103337T2 (tr) | Protez inhibitrleri olarak yeni bileçikler ve bileçimler | |
| EA200300381A1 (ru) | Нуклеиновые кислоты и полипептиды нового рецептора | |
| MX336118B (es) | Expresion hibrida y en tandem de proteinas de neisseria. | |
| CY1109463T1 (el) | Πεπτιδια kdr και εμβολια που τα περιλαμβανουν | |
| CY1112330T1 (el) | Πρωτεϊνες συνδεσης gag | |
| DK1151102T3 (da) | Glycosylerede leptinpræparater og relaterede fremgangsmåder | |
| WO2002048180A3 (de) | Peptide und/oder proteine sowie verwendung desselben zur herstellung eines therapeutischen und/oder präventiven arzneimittels | |
| DE3856240T2 (de) | Herstellung der p1 proteine und impfstoffe gegen gonorrhöe | |
| IL152406A0 (en) | Anti-freeze proteins, their production and use | |
| ATE408631T1 (de) | Chimäres protein welches eine intramolekulare chaperon-ähnliche sequenz enthält und dessen anwendung zur insulinproduktion | |
| DE60322064D1 (de) | 4,4' -dithiobis- (3-aminobutane-1-sulfonate)-derivate und sie enthaltende zusammensetzungen | |
| HUP0302566A2 (hu) | Készítmények és eljárások emlőrák gyógykezelésére és diagnosztizálására | |
| AU6011001A (en) | Novel lhrh-antagonists, production and use thereof as medicament | |
| BR0211991A (pt) | HormÈnio do crescimento humano modificado | |
| DK0866861T3 (da) | Molekylær kloning og karakterisering af molekyler forbundet med relaxin og ligandinsulinfamilien | |
| DE69834929D1 (de) | Verwendung eines organspezifischen ernährungmittels | |
| WO2005058944A3 (en) | Immunogenic peptides fragments of xage-1 | |
| ATE281522T1 (de) | Sentrin-spezifische menschliche protease senp1 | |
| IL150045A0 (en) | Compositions and methods for detecting stress-inducible proteins | |
| BR0315650A (pt) | Vetor lócus de expressão elevada com base no lócus do gene de cadeia pesada de ferritina | |
| CY1113593T1 (el) | Σκευασματα ανταγωνιστη il-1 |